Targeted therapies for ER+/HER2- metastatic breast cancer

por Yamamoto-Ibusuki, Mutsuko, Arnedos, Monica, André, Fabrice
Publicado 2015

A comprehensive analysis of Aurora A; transcript levels are the most reliable in association with proliferation and prognosis in breast cancer

por Yamamoto, Satoko, Yamamoto-Ibusuki, Mutsuko, Yamamoto, Yutaka, Fujiwara, Saori, Iwase, Hirotaka
Publicado 2013

Differential expression of exosomal miRNAs between breast cancer patients with and without recurrence

por Sueta, Aiko, Yamamoto, Yutaka, Tomiguchi, Mai, Takeshita, Takashi, Yamamoto-Ibusuki, Mutsuko, Iwase, Hirotaka
Publicado 2017

An Integrative Analysis of PIK3CA Mutation, PTEN, and INPP4B Expression in Terms of Trastuzumab Efficacy in HER2-Positive Breast Cancer

por Sueta, Aiko, Yamamoto, Yutaka, Yamamoto-Ibusuki, Mutsuko, Hayashi, Mitsuhiro, Takeshita, Takashi, Yamamoto, Satoko, Iwase, Hirotaka
Publicado 2014

Clinical significance of plasma cell-free DNA mutations in PIK3CA, AKT1, and ESR1 gene according to treatment lines in ER-positive breast cancer

por Takeshita, Takashi, Yamamoto, Yutaka, Yamamoto-Ibusuki, Mutsuko, Tomiguchi, Mai, Sueta, Aiko, Murakami, Keiichi, Iwase, Hirotaka
Publicado 2018

A progressive and refractory case of breast cancer with Cowden syndrome

por Sueta, Aiko, Takeno, Masako, Goto-Yamaguchi, Lisa, Tomiguchi, Mai, Inao, Toko, Yamamoto-Ibusuki, Mutsuko, Yamamoto, Yutaka
Publicado 2022

Prognostic role of PIK3CA mutations of cell‐free DNA in early‐stage triple negative breast cancer

por Takeshita, Takashi, Yamamoto, Yutaka, Yamamoto‐Ibusuki, Mutsuko, Inao, Toko, Sueta, Aiko, Fujiwara, Saori, Omoto, Yoko, Iwase, Hirotaka
Publicado 2015

Associations Between Elastography Findings and Clinicopathological Factors in Breast Cancer

por Hayashi, Mitsuhiro, Yamamoto, Yutaka, Sueta, Aiko, Tomiguchi, Mai, Yamamoto-Ibusuki, Mutsuko, Kawasoe, Teru, Hamada, Akinobu, Iwase, Hirotaka
Publicado 2015

Clinical significance of monitoring ESR1 mutations in circulating cell-free DNA in estrogen receptor positive breast cancer patients

por Takeshita, Takashi, Yamamoto, Yutaka, Yamamoto-Ibusuki, Mutsuko, Inao, Toko, Sueta, Aiko, Fujiwara, Saori, Omoto, Yoko, Iwase, Hirotaka
Publicado 2016

The Clinical Significance of CD169-Positive Lymph Node Macrophage in Patients with Breast Cancer

por Shiota, Takuya, Miyasato, Yuko, Ohnishi, Koji, Yamamoto-Ibusuki, Mutsuko, Yamamoto, Yutaka, Iwase, Hirotaka, Takeya, Motohiro, Komohara, Yoshihiro
Publicado 2016

Clinical features of lenvatinib treatment in elderly patients with advanced thyroid cancer

por Suyama, Koichi, Fujiwara, Saori, Takeshita, Takashi, Sueta, Aiko, Inao, Touko, Yamamoto-Ibusuki, Mutsuko, Yamamoto, Yutaka, Iwase, Hirotaka
Publicado 2017

Comparison of ESR1 Mutations in Tumor Tissue and Matched Plasma Samples from Metastatic Breast Cancer Patients

por Takeshita, Takashi, Yamamoto, Yutaka, Yamamoto-Ibusuki, Mutsuko, Tomiguchi, Mai, Sueta, Aiko, Murakami, Keiichi, Omoto, Yoko, Iwase, Hirotaka
Publicado 2017

Analysis of ESR1 and PIK3CA mutations in plasma cell-free DNA from ER-positive breast cancer patients

por Takeshita, Takashi, Yamamoto, Yutaka, Yamamoto-Ibusuki, Mutsuko, Tomiguchi, Mai, Sueta, Aiko, Murakami, Keiichi, Omoto, Yoko, Iwase, Hirotaka
Publicado 2017

Prevalence of ESR1 E380Q mutation in tumor tissue and plasma from Japanese breast cancer patients

por Takeshita, Takashi, Yamamoto, Yutaka, Yamamoto-Ibusuki, Mutsuko, Sueta, Aiko, Tomiguchi, Mai, Murakami, Keiichi, Omoto, Yoko, Iwase, Hirotaka
Publicado 2017

PTIP Associated protein 1, PA1, Is an Independent Prognostic Factor for Lymphnode Negative Breast Cancer

por Takeshita, Takashi, Yamamoto-Ibusuki, Mutsuko, Yamamoto, Yutaka, Omoto, Yoko, Honda, Yumi, Iyama, Ken-ichi, Zhang, Zhenhuan, Iwase, Hirotaka
Publicado 2013

APOBEC3B gene expression as a novel predictive factor for pathological complete response to neoadjuvant chemotherapy in breast cancer

por Fujiki, Yoshitaka, Yamamoto, Yutaka, Sueta, Aiko, Yamamoto-Ibusuki, Mutsuko, Goto-Yamaguchi, Lisa, Tomiguchi, Mai, Takeshita, Takashi, Iwase, Hirotaka
Publicado 2018

Immunohistochemical analysis in ethinylestradiol-treated breast cancers after prior long-term estrogen-deprivation therapy

por Omoto, Yoko, Takeshita, Takashi, Yamamoto, Yutaka, Yamamoto-Ibusuki, Mutsuko, Hayashi, Mitsuhiro, Sueta, Aiko, Fujiwara, Saori, Taguchi, Tetsuya, Iwase, Hirotaka
Publicado 2015

BRCAness as an Important Prognostic Marker in Patients with Triple-Negative Breast Cancer Treated with Neoadjuvant Chemotherapy: A Multicenter Retrospective Study

por Kosaka, Yoshimasa, Yamamoto, Yutaka, Tanino, Hirokazu, Nishimiya, Hiroshi, Yamamoto-Ibusuki, Mutsuko, Hirota, Yuko, Iwase, Hirotaka, Nakamura, Seigo, Akashi-Tanaka, Sadako
Publicado 2020

Identification of biomarkers in ductal carcinoma in situ of the breast with microinvasion

por Okumura, Yasuhiro, Yamamoto, Yutaka, Zhang, Zhenhuan, Toyama, Tatsuya, Kawasoe, Teru, Ibusuki, Mutsuko, Honda, Yumi, Iyama, Ken-ichi, Yamashita, Hiroko, Iwase, Hirotaka
Publicado 2008

Randomized controlled trial of toremifene 120 mg compared with exemestane 25 mg after prior treatment with a non-steroidal aromatase inhibitor in postmenopausal women with hormone...

por Yamamoto, Yutaka, Ishikawa, Takashi, Hozumi, Yasuo, Ikeda, Masahiko, Iwata, Hiroji, Yamashita, Hiroko, Toyama, Tatsuya, Chishima, Takashi, Saji, Shigehira, Yamamoto-Ibusuki, Mutsuko, Iwase, Hirotaka
Publicado 2013